Jacob J, Rose D, Stilson M, Davis R F, Gilbert D
Crit Care Med. 1986 Dec;14(12):1050-2. doi: 10.1097/00003246-198612000-00011.
We studied the value of transcutaneous carbon dioxide (PtcCO2) monitoring during neonatal transport. Thirty-two neonates with respiratory distress were alternately enrolled in an experimental group (results of PtcO2 and PtcCO2 available for clinical management) and a control group (results of only PtcO2 available). Although differences were not significant, infants in the experimental group had more changes in the intermittent mandatory ventilation (IMV) settings during transport, and more such infants arrived at the receiving hospital with acceptable pH and PCO2 values. On arrival at the receiving hospital, two patients in the control group had acidosis and hypercarbia and were placed on IMV immediately on arrival. No such patients were encountered in the experimental group. For patients needing IMV during transport, the percentage of study time spent with PtcCO2 measurements in the normal range (35 to 45 torr) was greater for the experimental group (p less than .02). Continuous PtcCO2 monitoring during transport offers the opportunity to further decrease the risks of transporting a critically ill neonate.
我们研究了新生儿转运期间经皮二氧化碳（PtcCO2）监测的价值。32例呼吸窘迫的新生儿被交替纳入实验组（可获得PtcO2和PtcCO2结果用于临床管理）和对照组（仅可获得PtcO2结果）。尽管差异不显著，但实验组婴儿在转运期间间歇指令通气（IMV）设置的变化更多，且更多此类婴儿到达接收医院时pH值和PCO2值可接受。到达接收医院时，对照组有2例患者出现酸中毒和高碳酸血症，到达后立即接受IMV治疗。实验组未遇到此类患者。对于转运期间需要IMV的患者，实验组在PtcCO2测量值处于正常范围（35至45托）的研究时间百分比更高（p小于0.02）。转运期间持续的PtcCO2监测为进一步降低危重新生儿转运风险提供了机会。
